Parnax Lab LtdPharmaceuticalsINE383L01019
Valuation
Market Cap₹143.91 Cr
TTM PE95.65x
Forward PE106.79x
PEG0.74
Book Value₹737.06
P/B0.17x
TTM EPS₹1.31
Fwd EPS₹1.17
TTM Revenue₹7.23 Cr
TTM PAT₹0.77 Cr
TTM EBITDA₹-1.07 Cr
TTM EBIT₹-1.15 Cr
Last Qtr PAT₹-1.28 Cr
Last Qtr EBITDA₹0.66 Cr
Last Qtr EBIT₹0.64 Cr
Profitability
ROE—
ROCE—
TTM NPM10.65%
TTM EBITDA %-14.80%
Curr OPM32.94%
Last OPM-516.13%
Curr NPM—
Last NPM—
Curr EPS₹0.74
Last EPS₹-0.48
Balance sheet
Equity—
Reserve—
Total Debt₹0.00 Cr
D/E—
Interest %0.00%
Curr Interest₹0.00 Cr
Price / range
Close₹125.30
vs 52W High-31.15%
vs 52W Low+26.31%
MA50—
MA200—
Returns
1D+1.21%
1W-1.38%
1M+6.19%
3M-6.53%
6M+4.42%
1Y-8.10%
2Y+4.42%
3Y+35.90%
5Y+436.62%
Diwali-3.32%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits
Dividend
0No dividend history.